Emergency Medicine has a scientifically derived and commonly accepted description of the domain of its clinical practice. That document, The Model of the Clinical Practice of Emergency Medicine (EM Model), was developed through the collaboration of six organizations: the American Board of Emergency Medicine (ABEM), the administrative organization for the project, the American College of Emergency Physicians (ACEP), the Council of Emergency Medicine Residency Directors (CORD), the Emergency Medicine Residents' Association (EMRA), the Residency Review Committee for Emergency Medicine (RRC-EM), and the Society for Academic Emergency Medicine (SAEM). Development of the EM Model was based on an extensive practice analysis of the specialty. The practice analysis relied on both empiric data gathered from actual emergency department visits and several expert panels (
1
). The resulting product was first published in 2001, and has successfully served as the common source document for all emergency medicine organizations (2
,3
). One of its strengths is incorporating the reality that emergency medicine is a specialty driven by symptoms not diagnoses, requiring simultaneous therapeutic and diagnostic interventions.The task force that developed the EM Model recommended that a new task force, composed of representatives from all six organizations, be formed every 2 years to assess the success of the document in accomplishing its objective of supporting the ongoing development of the specialty of emergency medicine; to consider alterations to the EM Model suggested by the collaborating organizations; and to recommend changes to the six sponsoring organizations.
The initial 2-year review occurred in 2003, with representatives from each of the six organizations suggesting changes and reporting how their respective organizations had used the document. The initial 2-year update was published in Annals of Emergency Medicine and Academic Emergency Medicine in 2005 (
4
,5
). Subsequently, a task force met every 2 years to review the EM Model and recommend changes (6
, 7
, 8
, 9
, 10
, 11
, 12
, 13
). In 2013, a seventh organization, the American Academy of Emergency Medicine (AAEM), was added as a collaborating organization. In 2014, the collaborating organizations made the decision to review the EM Model on a 3-year review cycle, beginning in 2016. The 2016 update was published in Journal of Emergency Medicine in 2017 (14
). In 2019, the AAAEM Resident and Student Association was added as an eighth collaborating organization.This article provides a brief review of the original EM Model, along with the changes to the EM Model as recommended by the 2019 EM Model Review Task Force. Significant changes occurred with the 2019 review, including the addition of oncologic emergencies in the newly renamed “Category 8, Hematologic and Oncologic Disorders.” A summary of all 2019 changes and an update on current uses of the EM Model by the seven collaborating EM organizations are also included in this article.
The EM Model
The EM Model is a three-dimensional description of EM clinical practice. The three dimensions are patient acuity; physician tasks; and a listing of medical knowledge, patient care, and procedural skills. All of these dimensions are interrelated and used concurrently by a physician when providing patient care. The emergency physician's initial approach is determined by the acuity of the patient's presentation. While assessing the patient, the physician completes a series of tasks in collecting information. Through this process, the physician is able to select the possible etiologies of the patient's problem from the listing of medical knowledge, patient care, and procedural skills. Through simultaneous application of all three components, the physician is able to determine the most probable diagnosis and implement a treatment plan for the patient. The three dimensions, as revised in 2019, are included in Table 1, Table 2, Table 3, Table 4.
Table 1Matrix of Physician Tasks by Patient Acuity
Physician Tasks | Patient Acuity | ||
---|---|---|---|
Critical | Emergent | Lower Acuity | |
Prehospital care Emergency stabilization Performance of focused history and physical examination Modifying factors Professional issues Legal issues Diagnostic studies Diagnosis Therapeutic interventions Pharmacotherapy Observation and reassessment Consultation Transitions of care Prevention and education Documentation Task switching/Multiple patient care Team management Mass casualty/Disaster management Patient-centered communication skills Prognosis |
Table 2Patient Acuity Definitions
Critical | Emergent | Lower Acuity |
---|---|---|
Patient presents with symptoms of a life-threatening illness or injury with a high probability of mortality if immediate intervention is not begun to prevent further airway, respiratory, hemodynamic, and/or neurologic instability. | Patient presents with symptoms of an illness or injury that may progress in severity or result in complications with a high probability for morbidity if treatment is not begun quickly. | Patient presents with symptoms of an illness or injury that have a low probability of progression to more serious disease or development of complications. |
Table 3Physician Task Definitions
Physician Task | Definition |
---|---|
Prehospital care | Participate actively in prehospital care; provide direct patient care or on-line or off-line medical direction or interact with prehospital medical providers; assimilate information from prehospital care into the assessment and management of the patient. |
Emergency stabilization | Conduct primary assessment and take appropriate steps to stabilize and treat patients. |
Performance of focused history and physical examination | Effectively interpret and evaluate the patient's symptoms and history; identify pertinent risk factors in the patient's history; provide a focused evaluation; interpret the patient's appearance, vital signs and condition; recognize pertinent physical findings; perform techniques required for conducting the examination. |
Modifying factors | Recognize age, gender, ethnicity, barriers to communication, socioeconomic status, underlying disease, gender identity, sexual orientation, and other factors that may affect patient management. |
Professional issues | Understand and apply principles of professionalism and ethics pertinent to patient management. |
Legal issues | Understand and apply legal concepts pertinent to the practice of emergency medicine. |
Diagnostic studies | Select and perform the most appropriate diagnostic studies and interpret the results, e.g., electrocardiogram, emergency ultrasound, and radiographic and laboratory tests. |
Diagnosis | Develop a differential diagnosis and establish the most likely diagnosis in light of the history, physical, interventions, and test results. |
Therapeutic interventions | Perform procedures and nonpharmacologic therapies, and counsel. |
Pharmacotherapy | Select, prescribe, and be aware of adverse effects of appropriate pharmaceutical agents based on relevant considerations such as intended effect, financial considerations, possible adverse effects, patient preferences, institutional policies, and clinical guidelines; monitor and intervene in the event of adverse effects in the emergency department. |
Observation and reassessment | Evaluate and re-evaluate the effectiveness of a patient's treatment or therapy, including addressing complications and potential errors; monitor, observe, manage, and maintain the stability of one or more patients who are at different stages in their workups. |
Consultation | Collaborate with physicians and other professionals to help guide optimal management of patients. |
Transitions of care | Arrange for patient admission, discharge (including follow-up plan), observation, or transfer and transitions of care as appropriate, and communicate these arrangements effectively with patients, family, and involved health care team members. |
Prevention and education | Apply epidemiologic information to patients at risk; conduct patient education; select appropriate disease and injury prevention, and harm reduction techniques. |
Documentation | Communicate patient care information in a concise and appropriate manner that facilitates quality care. This includes documentation and medical decision-making variables related to billing, coding, and reimbursement for patient care. |
Task switching/Multiple patient care | Prioritize and implement the evaluation and management of multiple patients in the emergency department, including handling interruptions and task-switching, in order to provide optimal patient care. |
Team management | Coordinate, educate, or supervise members of the patient management team and utilize appropriate hospital resources. |
Mass casualty/Disaster management | Understand and apply the principles of disaster and mass casualty management including preparedness, triage, mitigation, response, and recovery. |
Patient-centered communication skills | Establish rapport with and demonstrate empathy toward patients and their families; listen effectively to patients and their families. Identify situations that require individualized communication, such as goals of care, end of life care, and palliative options. |
Prognosis | Forecast the likely outcome of a medical disease or traumatic condition. |
Table 4Medical Knowledge, Patient Care, and Procedural Skills
1.0 SIGNS, SYMPTOMS, AND PRESENTATIONS | |||
---|---|---|---|
Critical | Emergent | Lower Acuity | |
1.1 Abnormal Vital Signs | |||
1.1.1 Hypothermia | X | X | X |
1.1.2 Fever | X | X | X |
1.1.3 Bradycardia | X | X | X |
1.1.4 Tachycardia | X | X | |
1.1.5 Bradypnea/Apnea | X | X | |
1.1.6 Tachypnea | X | X | |
1.1.7 Hypoxia | X | X | |
1.1.8 Hypotension | X | X | |
1.1.9 Hypertension | X | X | X |
1.2 Pain | |||
1.2.1 Pain (unspecified) | X | X | X |
1.2.2 Headache (See 12.3) | X | X | X |
1.2.3 Eye pain | X | X | |
1.2.4 Chest pain | X | X | X |
1.2.5 Abdominal pain | X | X | X |
1.2.6 Pelvic and genital pain | X | X | X |
1.2.7 Back pain | X | X | X |
1.2.8 Chronic pain | X | ||
1.2.9 Extremity pain | X | X | X |
1.2.10 Neck pain | X | X | X |
1.3 General | |||
1.3.1 Altered mental status | X | X | X |
1.3.2 Anuria/Oliguria | X | ||
1.3.3 Ascites | X | X | |
1.3.4 Ataxia | X | X | |
1.3.5 Auditory disturbances | X | ||
1.3.6 Bleeding | X | X | X |
1.3.7 Congestion/Rhinorrhea | X | ||
1.3.8 Constipation/Obstipation | X | X | |
1.3.9 Cough | X | X | |
1.3.10 Crying/Fussiness | X | X | |
1.3.11 Cyanosis | X | ||
1.3.12 Dehydration | X | X | |
1.3.13 Diarrhea | X | X | |
1.3.14 Dysmenorrhea | X | ||
1.3.15 Dysphagia | X | X | |
1.3.16 Dysuria | X | ||
1.3.17 Edema | X | X | |
1.3.18 Failure to thrive | X | X | |
1.3.19 Fatigue/Malaise | X | X | |
1.3.20 Feeding problems | X | ||
1.3.21 Hematemesis | X | X | |
1.3.22 Hematuria | X | X | |
1.3.23 Hemoptysis | X | X | |
1.3.24 Hiccup | X | ||
1.3.25 Jaundice | X | ||
1.3.26 Joint swelling | X | X | |
1.3.27 Lethargy | X | X | X |
1.3.28 Lightheadedness/Dizziness | X | X | |
1.3.29 Limp | X | X | |
1.3.30 Lymphadenopathy | X | ||
1.3.31 Mechanical and indwelling devices, complications | X | X | X |
1.3.32 Nausea/Vomiting | X | X | |
1.3.33 Occupational exposure | X | X | |
1.3.34 Palpitations | X | X | X |
1.3.35 Paralysis | X | X | |
1.3.36 Paresthesia/Dysesthesia | X | X | |
1.3.37 Poisoning | X | X | X |
1.3.38 Pruritus | X | X | |
1.3.39 Rash | X | X | X |
1.3.40 Rectal bleeding | X | X | X |
1.3.41 Shock | X | ||
1.3.42 Shortness of breath | X | X | |
1.3.43 Sore throat | X | X | |
1.3.44 Stridor | X | X | |
1.3.45 Syncope/Near syncope | X | X | X |
1.3.46 Tinnitus | X | ||
1.3.47 Tremor | X | X | |
1.3.48 Urinary incontinence | X | ||
1.3.49 Urinary retention | X | ||
1.3.50 Vaginal bleeding | X | X | X |
1.3.51 Vaginal discharge | X | ||
1.3.52 Visual disturbances | X | X | |
1.3.53 Weakness | X | X | |
1.3.54 Wheezing | X | X | |
1.3.55 Toxidromes | X | X | X |
1.3.56 Sudden unexpected infant death (SUID) | X | ||
1.3.57 Suicidal ideation | X | X | X |
1.3.58 Brief resolved unexplained events (BRUE) | X | X | X |
1.3.59 Intoxication syndromes | X | X | X |
1.3.60 Postsurgical complications | X | X | X |
2.0 ABDOMINAL AND GASTROINTESTINAL DISORDERS | |||
Critical | Emergent | Lower Acuity | |
2.1 Abdominal Wall | |||
2.1.1 Hernias | X | X | |
2.1.2 Hematoma | X | ||
2.2 Esophagus | |||
2.2.1 Infectious disorders | |||
2.2.1.1 Candida (See 4.4.2.1, 7.4.6) | X | X | |
2.2.1.2 Viral esophagitis | X | X | |
2.2.2 Inflammatory disorders | |||
2.2.2.1 Esophagitis | X | X | |
2.2.2.2 Gastroesophageal reflux (GERD) | X | ||
2.2.2.3 Toxic effects of caustic agents (See 17.1.16.1) | |||
2.2.2.3.1 Acid | X | X | |
2.2.2.3.2 Alkali | X | X | |
2.2.3 Motor abnormalities | |||
2.2.4 Structural disorders | |||
2.2.4.1 Boerhaave's syndrome | X | X | |
2.2.4.2 Diverticula | X | X | |
2.2.4.3 Foreign body | X | ||
2.2.4.4 Hernias | X | X | |
2.2.4.5 Mallory-Weiss syndrome | X | X | |
2.2.4.6 Stricture and stenosis | X | X | |
2.2.4.7 Tracheoesophageal fistula | X | X | |
2.2.4.8 Varices | X | X | |
2.2.5 Tumors | X | X | |
2.3 Liver | |||
2.3.1 Noninfectious hepatitis/Cirrhosis | X | X | |
2.3.1.1 Alcoholic | X | X | |
2.3.1.2 Biliary obstructive | X | ||
2.3.1.3 Drug-induced | X | X | |
2.3.1.4 Nonalcoholic steatohepatitis (NASH) | X | ||
2.3.2 Hepatorenal failure | X | X | |
2.3.3 Infectious disorders | X | X | |
2.3.3.1 Abscess | X | ||
2.3.3.2 Hepatitis | X | ||
2.3.3.3 Perihepatitis | X | ||
2.3.4 Tumors | X | X | |
2.3.5 Hepatic encephalopathy | X | X | |
2.4 Gallbladder and Biliary Tract | |||
2.4.1 Cholangitis | X | X | |
2.4.2 Cholecystitis | X | X | |
2.4.3 Cholelithiasis/Choledocholithiasis | X | X | |
2.4.4 Tumors | X | X | |
2.5 Pancreas | |||
2.5.1 Pancreatitis | X | X | |
2.5.2 Tumors | X | X | |
2.5.3 Pseudocyst | X | ||
2.6 Peritoneum | |||
2.6.1 Spontaneous bacterial peritonitis | X | X | |
2.6.2 Abdominal compartment syndrome | X | X | |
2.7 Stomach | |||
2.7.1 Infectious disorders | X | ||
2.7.2 Inflammatory disorders | |||
2.7.2.1 Gastritis | X | X | |
2.7.3 Peptic ulcer disease | X | X | |
2.7.3.1 Hemorrhage | X | X | |
2.7.3.2 Perforation | X | X | |
2.7.4 Structural disorders | |||
2.7.4.1 Congenital hypertrophic pyloric stenosis | X | ||
2.7.4.2 Foreign body | X | X | |
2.7.5 Tumors | X | X | |
2.7.6 Gastroparesis | X | X | |
2.7.7 Cyclic vomiting syndrome (See 17.1.24.1.1) | X | X | |
2.8 Small Bowel | |||
2.8.1 Infectious disorders | X | X | |
2.8.2 Inflammatory disorders | |||
2.8.1.1 Regional enteritis/Crohn's disease | X | X | |
2.8.1.2 Gluten enteropathy/Celiac disease | X | ||
2.8.3 Motor abnormalities | |||
2.8.3.1 Obstruction | X | X | |
2.8.3.2 Paralytic ileus | X | ||
2.8.4 Structural disorders | |||
2.8.4.1 Aortoenteric fistula | X | ||
2.8.4.2 Congenital anomalies | X | X | |
2.8.4.3 Intestinal malabsorption | X | X | |
2.8.4.4 Meckel's diverticulum | X | X | |
2.8.5 Tumors | X | X | |
2.8.6 Vascular insufficiency | X | X | |
2.9 Large Bowel | |||
2.9.1 Infectious disorders | |||
2.9.1.1 Antibiotic-associated | X | ||
2.9.1.2 Bacterial | X | X | |
2.9.1.3 Parasitic | X | X | |
2.9.1.4 Viral | X | X | |
2.9.2 Inflammatory disorders | |||
2.9.2.1 Appendicitis | X | ||
2.9.2.2 Necrotizing enterocolitis (NEC) | X | X | |
2.9.2.3 Radiation colitis | X | ||
2.9.2.4 Ulcerative colitis | X | X | |
2.9.2.5 Neutropenic enterocolitis/Typhlitis | X | X | |
2.9.3 Motor abnormalities | |||
2.9.3.1 Hirschsprung's disease | X | X | |
2.9.3.2 Irritable bowel | X | ||
2.9.3.3 Obstruction | X | X | |
2.9.4 Structural disorders | |||
2.9.4.1 Congenital anomalies | X | X | |
2.9.4.2 Diverticula | X | X | |
2.9.4.3 Intussusception | X | X | |
2.9.4.4 Volvulus | X | X | |
2.9.5 Tumors | X | X | |
2.10 Rectum and Anus | |||
2.10.1 Infectious disorders | |||
2.10.1.1 Perianal/Anal abscess | X | X | |
2.10.1.2 Perirectal abscess | X | ||
2.10.1.3 Pilonidal cyst and abscess | X | X | |
2.10.2 Inflammatory disorders | |||
2.10.2.1 Proctitis | X | ||
2.10.3 Structural disorders | |||
2.10.3.1 Anal fissure | X | ||
2.10.3.2 Anal fistula | X | X | |
2.10.3.3 Congenital anomalies | X | ||
2.10.3.4 Foreign body | X | X | |
2.10.3.5 Hemorrhoids | X | ||
2.10.3.6 Rectal prolapse | X | ||
2.10.4 Tumors | X | X | |
2.11 Spleen | |||
2.11.1 Asplenism | X | X | |
2.11.2 Splenomegaly | X | ||
2.11.3 Vascular insufficiency/Infarction | X | X | X |
2.12 Specific Post-surgical Populations | |||
2.12.1 Bariatric surgery | X | X | X |
2.12.2 Ostomy | X | X | |
3.0 CARDIOVASCULAR DISORDERS | |||
Critical | Emergent | Lower Acuity | |
3.1 Cardiopulmonary Arrest | X | ||
3.2 Congenital Abnormalities of the Cardiovascular System | X | X | X |
3.2.1 Tetralogy of Fallot spells | X | X | |
3.2.2 Patent ductus arteriosus-dependent congenital heart anomalies | X | X | |
3.3 Disorders of Circulation | |||
3.3.1 Arterial | |||
3.3.1.1 Aneurysm | X | X | X |
3.3.1.2 Dissection | X | ||
3.3.1.2.1 Aortic | X | X | X |
3.3.1.2.2 Non-aortic | X | X | X |
3.3.1.3 Thromboembolism | X | X | |
3.3.2 Venous | |||
3.3.2.1 Thromboembolism (See 16.6.2) | X | X | |
3.4 Disturbances of Cardiac Rhythm | |||
3.4.1 Cardiac dysrhythmias | X | X | X |
3.4.1.1 Ventricular | X | X | |
3.4.1.2 Supraventricular | X | X | X |
3.4.1.3 Pulseless electrical activity | X | ||
3.4.2 Conduction disorders | X | X | X |
3.5 Diseases of the Myocardium, Acquired | |||
3.5.1 Cardiac failure | X | X | |
3.5.1.1 Cor pulmonale | X | X | |
3.5.1.2 High output | X | X | |
3.5.1.3 Low output | X | X | |
3.5.2 Cardiomyopathy | X | X | X |
3.5.2.1 Hypertrophic | X | X | X |
3.5.2.2 Dilated | X | X | X |
3.5.3 Congestive heart failure | X | X | |
3.5.4 Coronary syndromes | X | X | |
3.5.5 Ischemic heart disease | X | X | |
3.5.6 Myocardial infarction | X | X | |
3.5.7 Myocarditis | X | X | X |
3.5.8 Ventricular aneurysm | X | X | X |
3.6 Diseases of the Pericardium | |||
3.6.1 Pericardial tamponade (See 18.1.2.6) | X | X | |
3.6.2 Pericarditis | X | X | |
3.7 Hypertension | X | X | X |
3.7.1 Asymptomatic hypertension | X | ||
3.7.2 Hypertensive emergency | X | X | |
3.8 Tumors | X | X | |
3.9 Valvular Disorders | X | X | X |
3.9.1 Endocarditis | X | X | |
3.10 Cardiovascular Devices | |||
3.10.1 Pacemaker/Automatic implantable cardioverter-defibrillator (AICD) | X | X | X |
3.10.2 Left ventricular assist device (LVAD) | X | X | X |
4.0 CUTANEOUS DISORDERS | |||
Critical | Emergent | Lower Acuity | |
4.1 Cancers of the Skin | |||
4.1.1 Basal cell | X | ||
4.1.2 Kaposi's sarcoma | X | ||
4.1.3 Melanoma | X | ||
4.1.4 Squamous cell | X | ||
4.2 Ulcerative Lesions | |||
4.2.1 Decubitus | X | X | |
4.2.2 Venous stasis | X | ||
4.2.3 Diabetic foot ulcers | X | X | |
4.3 Dermatitis | |||
4.3.1 Atopic/Eczema | X | ||
4.3.2 Contact | X | ||
4.3.3 Psoriasis | X | ||
4.3.4 Seborrhea | X | ||
4.4 Infections | |||
4.4.1 Bacterial | |||
4.4.1.1 Abscess | X | X | |
4.4.1.2 Cellulitis | X | X | |
4.4.1.3 Erysipelas | X | ||
4.4.1.4 Impetigo | X | ||
4.4.1.5 Necrotizing infection | X | X | |
4.4.2 Fungal | |||
4.4.2.1 Candida (See 2.2.1.1, 7.4.6) | X | ||
4.4.2.2 Dermatophytes | X | ||
4.4.3 Ectoparasites | X | ||
4.4.4 Viral | |||
4.4.4.1 Aphthous ulcers | X | ||
4.4.4.2 Childhood exanthems (See 10.6.8, 10.6.9) | X | ||
4.4.4.3 Herpetic infections (See 10.6.4, 10.6.5, 13.1.3.1) | X | X | |
4.4.4.4 Human papillomavirus (HPV) (See 13.1.3.2) | X | ||
4.4.4.5 Molluscum contagiosum | X | ||
4.5 Maculopapular Lesions | |||
4.5.1 Erythema multiforme | X | X | |
4.5.2 Pityriasis rosea | X | ||
4.5.3 Urticaria | X | X | |
4.5.4 Drug eruptions | X | X | |
4.6 Papular/Nodular Lesions | |||
4.6.1 Hemangioma/Lymphangioma | X | ||
4.6.2 Lipoma | X | ||
4.6.3 Sebaceous cyst | X | ||
4.6.4 Erythema nodosum | X | ||
4.7 Vesicular/Bullous Lesions | |||
4.7.1 Pemphigus | X | ||
4.7.2 Staphylococcal scalded skin syndrome | X | X | |
4.7.3 Stevens-Johnson syndrome | X | X | |
4.7.4 Toxic epidermal necrolysis | X | X | |
4.7.5 Bullous pemphigoid | X | X | |
4.8 Purpuric Rash | X | X | X |
4.8.1 Henoch-Schӧnlein purpura (HSP) | X | ||
5.0 ENDOCRINE, METABOLIC, AND NUTRITIONAL DISORDERS | |||
Critical | Emergent | Lower Acuity | |
5.1 Acid–base Disturbances | |||
5.1.1 Metabolic or respiratory | |||
5.1.1.1 Acidosis | X | X | |
5.1.1.2 Alkalosis | X | X | X |
5.1.2 Mixed acid–base balance disorder | X | X | |
5.2 Adrenal Disease | |||
5.2.1 Corticoadrenal insufficiency | X | X | |
5.2.2 Cushing's syndrome | X | X | |
5.3 Fluid and Electrolyte Disturbances | |||
5.3.1 Calcium metabolism | X | X | X |
5.3.2 Hypervolemia/Hypovolemia | X | X | X |
5.3.3 Potassium metabolism | X | X | X |
5.3.4 Sodium metabolism | X | X | X |
5.3.5 Magnesium metabolism | X | X | |
5.3.6 Phosphorus metabolism | X | X | |
5.4 Glucose Metabolism | |||
5.4.1 Diabetes mellitus | X | X | X |
5.4.1.1 Complications in glucose metabolism | |||
5.4.1.1.1 Hyperglycemia | X | X | |
5.4.1.1.2 Diabetic ketoacidosis (DKA) | X | X | X |
5.4.1.1.3 Hyperosmolar hyperglycemic state | X | X | |
5.4.1.1.4 Hypoglycemia | X | X | |
5.5 Nutritional Disorders | |||
5.5.1 Vitamin deficiencies | X | ||
5.5.2 Wernicke-Korsakoff syndrome | X | ||
5.5.3 Malabsorption | X | X | |
5.5.4 Malnutrition | X | X | |
5.6 Parathyroid Disease | X | X | |
5.7 Pituitary Disorders | X | X | |
5.7.1 Panhypopituitarism | X | ||
5.8 Thyroid Disorders | |||
5.8.1 Hyperthyroidism | X | X | X |
5.8.2 Hypothyroidism | X | X | X |
5.8.3 Thyroiditis | X | X | |
5.8.4 Thyroid storm | X | X | |
5.9 Tumors of Endocrine Glands | |||
5.9.1 Adrenal | X | X | |
5.9.1.1 Pheochromocytoma | X | X | |
5.9.2 Pituitary | X | X | |
5.9.3 Thyroid | X | X | |
6.0 ENVIRONMENTAL DISORDERS | |||
Critical | Emergent | Lower Acuity | |
6.1 Bites and Envenomation (See 18.1.3.2) | |||
6.1.1 Arthropods | X | X | |
6.1.1.1 Insects | X | ||
6.1.1.2 Arachnids | X | X | |
6.1.2 Mammals | X | X | |
6.1.3 Marine organisms (See 17.1.20) | X | X | X |
6.1.4 Reptiles | X | X | X |
6.2 Dysbarism | |||
6.2.1 Air embolism | X | X | |
6.2.2 Barotrauma | X | X | X |
6.2.3 Decompression syndrome | X | X | |
6.3 Electrical Injury (See 18.1.3.3.1) | X | X | X |
6.3.1 Lightning | X | X | |
6.4 High-altitude Illness | |||
6.4.1 Acute mountain sickness | X | X | |
6.4.2 High-altitude cerebral edema | X | X | |
6.4.3 High-altitude pulmonary edema | X | X | |
6.5 Submersion Incidents | X | X | X |
6.6 Temperature-related Illness | |||
6.6.1 Heat | X | X | X |
6.6.2 Cold | X | X | X |
6.6.2.1 Frostbite | X | X | |
6.6.2.2 Hypothermia | X | X | |
6.7 Radiation Emergencies | X | X | X |
7.0 HEAD, EAR, EYE, NOSE, THROAT DISORDERS | |||
Critical | Emergent | Lower Acuity | |
7.1 Ear | |||
7.1.1 Foreign body | X | X | |
7.1.1.1 Impacted cerumen | X | ||
7.1.2 Labyrinthitis | X | ||
7.1.3 Mastoiditis | X | ||
7.1.4 Ménière's disease | X | ||
7.1.5 Otitis externa | X | ||
7.1.5.1 Infective | X | ||
7.1.5.1.1 Malignant | X | ||
7.1.6 Otitis media | X | X | |
7.1.7 Perforated tympanic membrane (See 18.1.11.2) | X | ||
7.1.8 Perichondritis | X | X | |
7.2 Eye | |||
7.2.1 External eye | |||
7.2.1.1 Burn confined to eye (See 18.1.10.2) | X | ||
7.2.1.2 Conjunctivitis | X | ||
7.2.1.3 Corneal abrasions (See 18.1.10.1) | X | X | |
7.2.1.4 Disorders of lacrimal system | X | X | |
7.2.1.5 Foreign body | X | X | |
7.2.1.6 Disorders of the eyelids | X | ||
7.2.1.7 Keratitis | X | X | |
7.2.2 Anterior pole | |||
7.2.2.1 Glaucoma | X | X | |
7.2.2.2 Hyphema (See 18.1.10.5) | X | X | |
7.2.2.3 Iritis (See 18.1.10.8) | X | X | |
7.2.2.4 Hypopyon | X | ||
7.2.3 Posterior pole | |||
7.2.3.1 Choroiditis/Chorioretinitis | X | ||
7.2.3.2 Optic neuritis | X | ||
7.2.3.3 Papilledema | X | X | |
7.2.3.4 Retinal detachments and defects (See 18.1.10.7) | X | ||
7.2.3.5 Retinal vascular occlusion | X | ||
7.2.4 Orbit | |||
7.2.4.1 Cellulitis | |||
7.2.4.1.1 Preseptal | X | ||
7.2.4.1.2 Septal/Orbital | X | ||
7.2.4.2 Endophthalmitis | X | ||
7.3 Nose | |||
7.3.1 Epistaxis | X | X | X |
7.3.2 Foreign body | X | X | |
7.3.3 Rhinitis | X | ||
7.3.4 Sinusitis | X | ||
7.4 Oropharynx/Throat | |||
7.4.1 Dentalgia | X | ||
7.4.2 Diseases of the oral soft tissue | |||
7.4.2.1 Ludwig's angina | X | X | |
7.4.2.2 Stomatitis | X | ||
7.4.2.3 Gingival and periodontal disorders | X | X | |
7.4.2.4 Odontogenic infections/Abscesses | X | X | |
7.4.3 Diseases of the salivary glands | |||
7.4.3.1 Sialolithiasis | X | X | |
7.4.3.2 Suppurative parotitis | X | ||
7.4.4 Foreign body | X | X | |
7.4.5 Larynx/Trachea | |||
7.4.5.1 Epiglottitis (See 16.1.1.2) | X | X | |
7.4.5.2 Laryngitis | X | ||
7.4.5.3 Tracheitis | X | X | |
7.4.5.4 Tracheostomy complications | X | X | X |
7.4.6 Oral candidiasis (See 2.2.1.1, 4.4.2.1) | X | ||
7.4.7 Peritonsillar abscess | X | ||
7.4.8 Pharyngitis/Tonsillitis | X | ||
7.4.9 Retropharyngeal abscess | X | X | |
7.4.10 Temporomandibular joint disorders | X | ||
7.5 Tumors | X | X | X |
8.0 HEMATOLOGIC AND ONCOLOGIC DISORDERS | |||
Critical | Emergent | Lower Acuity | |
8.1 Blood Transfusion | |||
8.1.1 Complications | X | X | |
8.2 Hemostatic Disorders | |||
8.2.1 Coagulation defects | X | X | X |
8.2.1.1 Acquired | X | X | X |
8.2.1.2 Hemophilias | X | X | X |
8.2.1.3 Anticoagulation agents | X | X | X |
8.2.2 Disseminated intravascular coagulation | X | ||
8.2.3 Platelet disorders | X | X | X |
8.2.3.1 Thrombocytopenia | X | X | |
8.2.3.2 Idiopathic thrombocytopenic purpura | X | X | X |
8.2.3.3 Thrombotic thrombocytopenic purpura | X | X | |
8.3 Lymphomas | X | X | |
8.4 Pancytopenia | X | X | |
8.5 Red Blood Cell Disorders | |||
8.5.1 Anemias | |||
8.5.1.1 Aplastic | X | X | |
8.5.1.2 Hemoglobinopathies | X | X | |
8.5.1.2.1 Sickle cell anemia | X | X | X |
8.5.1.2.2 Thalassemia | X | X | |
8.5.1.3 Hemolytic | X | ||
8.5.1.4 Hypochromic | |||
8.5.1.4.1 Iron deficiency | X | X | |
8.5.1.5 Megaloblastic | X | X | |
8.5.2 Polycythemia | X | X | |
8.5.3 Methemoglobinemia (See 17.1.21) | X | X | |
8.6 White Blood Cell Disorders | |||
8.6.1 Leukemia | X | X | |
8.6.2 Multiple myeloma | X | X | |
8.6.3 Leukopenia | X | X | |
8.7 Oncologic Emergencies | X | X | X |
8.7.1 Febrile neutropenia | X | X | X |
8.7.2 Hypercalcemia of malignancy | X | X | X |
8.7.3 Hyperviscosity syndrome | X | X | X |
8.7.4 Malignant pericardial effusion | X | X | X |
8.7.5 Spinal cord compression (See 12.10) | X | X | |
8.7.6 Superior vena cava syndrome | X | X | |
8.7.7 Tumor hemorrhage | X | X | X |
8.7.8 Tumor lysis syndrome | X | X | |
9.0 IMMUNE SYSTEM DISORDERS | |||
Critical | Emergent | Lower Acuity | |
9.1 Collagen Vascular Disease | |||
9.1.1 Raynaud's disease | X | ||
9.1.2 Reactive arthritis (See 11.3.1.6) | X | X | |
9.1.3 Rheumatoid arthritis (See 11.3.1.3) | X | X | |
9.1.4 Scleroderma | X | X | |
9.1.5 Systemic lupus erythematosus | X | X | |
9.1.6 Vasculitis | X | X | |
9.2 Hypersensitivity | |||
9.2.1 Allergic reaction | X | X | |
9.2.2 Anaphylaxis | X | ||
9.2.3 Angioedema | X | X | |
9.2.4 Drug allergies | X | X | X |
9.3 Transplant-related Problems | X | X | X |
9.3.1 Immunosuppression | X | X | |
9.3.2 Rejection | X | X | |
9.4 Immune Complex Disorders | X | ||
9.4.1 Mucocutaneous lymph node syndrome (Kawasaki syndrome) | X | X | |
9.4.2 Rheumatic fever | X | X | |
9.4.3 Sarcoidosis | X | X | |
9.4.4 Post-streptococcal glomerulonephritis (See 15.3.1) | X | ||
9.5 Medication-induced Immunosuppression | X | X | |
9.5.1 Chemotherapeutic agents | X | X | |
9.5.2 Steroids | X | X | |
9.5.3 Targeted immune modulators | X | X | |
10.0 SYSTEMIC INFECTIOUS DISORDERS | |||
Critical | Emergent | Lower Acuity | |
10.1 Bacterial | |||
10.1.1 Bacterial food poisoning | X | X | |
10.1.1.1 Botulism | X | X | |
10.1.2 Chlamydia | X | X | |
10.1.3 Gonococcus | X | X | |
10.1.4 Meningococcus | X | X | |
10.1.5 Mycobacterium | |||
10.1.5.1 Atypical mycobacteria | X | X | |
10.1.5.2 Tuberculosis | X | X | |
10.1.6 Other bacterial diseases | X | X | |
10.1.6.1 Gas gangrene (See 11.6.3) | X | X | |
10.1.7 Sepsis/Bacteremia | X | X | |
10.1.7.1 Shock | X | ||
10.1.7.2 Toxic shock syndrome | X | X | |
10.1.8 Spirochetes | |||
10.1.8.1 Syphilis | X | X | |
10.1.9 Tetanus | X | X | |
10.2 Biological Warfare Agents | X | X | |
10.3 Fungal Infections | X | X | |
10.4 Protozoan/Parasites | |||
10.4.1 Malaria | X | ||
10.4.2 Toxoplasmosis | X | X | |
10.5 Tick-borne | |||
10.5.1 Anaplasmosis (Ehrlichiosis) | X | ||
10.5.2 Lyme disease | X | ||
10.5.3 Rocky Mountain spotted fever | X | ||
10.5.4 Babesiosis | X | ||
10.6 Viral | X | X | |
10.6.1 Infectious mononucleosis | X | X | |
10.6.2 Influenza/Parainfluenza | X | X | |
10.6.3 Arbovirus | X | X | X |
10.6.4 Herpes simplex (See 4.4.4.3, 13.1.3.1) | X | X | |
10.6.5 Herpes zoster/Varicella (See 4.4.4.3) | X | X | |
10.6.6 HIV/AIDS | X | X | X |
10.6.7 Rabies | X | ||
10.6.8 Roseola (See 4.4.4.2) | X | ||
10.6.9 Rubella (See 4.4.4.2) | X | ||
10.6.10 Measles | X | X | X |
10.6.11 Mumps (Paramyxovirus) | X | X | |
10.7 Emerging Infections/Pandemics | X | X | X |
10.8 Drug Resistance | X | X | X |
11.0 MUSCULOSKELETAL DISORDERS (NONTRAUMATIC) | |||
Critical | Emergent | Lower Acuity | |
11.1 Bony Abnormalities | |||
11.1.1 Aseptic/Avascular necrosis | X | X | |
11.1.2 Osteomyelitis | X | ||
11.1.3 Tumors | X | X | |
11.1.4 Atypical fractures | X | X | |
11.1.4.1 Osteoporotic | X | X | |
11.1.4.2 Tumor-related | X | X | |
11.1.4.3 Congenital disorders | X | X | |
11.2 Disorders of the Spine | |||
11.2.1 Disc disorders | X | X | |
11.2.2 Inflammatory/Infectious spondylopathies | X | X | |
11.2.3 Radiculopathy (See 12.7.3) | X | X | |
11.2.4 Spinal stenosis | X | X | |
11.2.5 Cervical pain | X | X | X |
11.2.6 Thoracic pain | X | X | X |
11.2.7 Lumbosacral pain | X | X | X |
11.2.7.1 Cauda equina syndrome (See 18.1.15.1) | X | X | |
11.2.7.2 Sacroiliitis | X | ||
11.2.7.3 Sciatica | X | X | |
11.2.8 Discitis | X | X | |
11.3 Joint Abnormalities | |||
11.3.1 Arthritis | |||
11.3.1.1 Septic | X | ||
11.3.1.2 Crystal arthropathies | X | X | |
11.3.1.3 Rheumatoid (See 9.1.3) | X | ||
11.3.1.4 Juvenile | X | ||
11.3.1.5 Osteoarthrosis | X | ||
11.3.1.6 Reactive arthritis (See 9.1.2) | X | X | |
11.3.2 Developmental dysplasia of the hip | X | X | |
11.3.3 Slipped capital femoral epiphysis | X | ||
11.3.4 Synovitis | X | X | |
11.4 Muscle Abnormalities | |||
11.4.1 Myositis | X | ||
11.4.2 Rhabdomyolysis | X | X | |
11.5 Overuse Syndromes | |||
11.5.1 Bursitis | X | ||
11.5.2 Muscle strains | X | ||
11.5.3 Peripheral nerve syndrome | X | ||
11.5.3.1 Carpal tunnel syndrome | X | ||
11.5.4 Tendinopathy | X | ||
11.5.5 Stress reaction fracture | X | X | |
11.6 Soft Tissue Infections | |||
11.6.1 Fasciitis | X | X | X |
11.6.2 Felon | X | ||
11.6.3 Gangrene (See 10.1.6.1) | X | X | |
11.6.4 Paronychia | X | X | |
11.6.5 Tenosynovitis | X | X | |
12.0 NERVOUS SYSTEM DISORDERS | |||
Critical | Emergent | Lower Acuity | |
12.1 Cranial Nerve Disorders | X | ||
12.1.1 Idiopathic facial nerve paralysis (Bell's palsy) | X | ||
12.1.2 Trigeminal neuralgia | X | ||
12.2 Demyelinating Disorders | X | X | |
12.2.1 Multiple sclerosis | X | X | |
12.3 Headache (See 1.2.2) | X | X | X |
12.3.1 Tension | X | ||
12.3.2 Vascular | X | X | |
12.3.3 Cluster | X | X | |
12.4 Hydrocephalus | X | X | |
12.4.1 Normal pressure | X | X | |
12.4.2 Shunt complications | X | ||
12.5 Infections/Inflammatory Disorders | |||
12.5.1 Encephalitis | X | X | |
12.5.2 Intracranial and intraspinal abscess | X | X | |
12.5.3 Meningitis | |||
12.5.3.1 Bacterial | X | X | |
12.5.3.2 Viral | X | X | X |
12.5.3.3 Fungal | X | X | X |
12.5.4 Myelitis | X | ||
12.5.4.1 Acute flaccid myelitis | X | ||
12.5.5 Neuritis | X | ||
12.6 Movement Disorders | X | X | |
12.6.1 Dystonic reaction | X | X | |
12.6.2 Chorea/Choreiform | X | ||
12.6.3 Tardive dyskinesia | X | ||
12.7 Neuromuscular Disorders | |||
12.7.1 Guillain-Barré syndrome | X | X | |
12.7.2 Myasthenia gravis | X | X | X |
12.7.3 Peripheral neuropathy (See 11.2.3) | X | ||
12.8 Other Conditions of the Brain | |||
12.8.1 Dementia (See 14.5.2) | X | ||
12.8.2 Parkinson's disease | X | ||
12.8.3 Idiopathic intracranial hypertension | X | X | |
12.8.4 Cerebral venous sinus thrombosis | X | X | X |
12.8.5 Posterior reversible encephalopathy syndrome (PRES) | X | X | |
12.8.6 Transient global amnesia | X | ||
12.9 Seizure Disorders | |||
12.9.1 Epileptiform | X | X | X |
12.9.1.1 Neonatal | X | X | |
12.9.1.2 Febrile | X | X | X |
12.9.1.3 Status epilepticus | X | ||
12.9.1.4 Nonconvulsiveac | X | X | |
12.9.1.5 Drug-induced | X | X | |
12.9.2 Nonepileptiform | X | ||
12.10 Spinal Cord Compression (See 8.7.5) | X | X | |
12.11 Stroke | |||
12.11.1 Hemorrhagic | |||
12.11.1.1 Intracerebral | X | X | |
12.11.1.2 Subarachnoid | X | X | |
12.11.2 Ischemic | |||
12.11.2.1 Embolic | X | X | |
12.11.2.2 Thrombotic | X | X | |
12.12 Transient Cerebral Ischemia | X | X | |
12.13 Tumors | X | X | X |
12.14 Delirium | X | X | X |
12.14.1 Excited delirium syndrome | X | X | |
13.0 OBSTETRICS AND GYNECOLOGY | |||
Critical | Emergent | Lower Acuity | |
13.1 Female Genital Tract | |||
13.1.1 Cervix | |||
13.1.1.1 Cervicitis and endocervicitis | X | X | |
13.1.1.2 Tumors | X | ||
13.1.2 Infectious disorders | |||
13.1.2.1 Pelvic inflammatory disease | X | ||
13.1.2.1.1 Fitz-Hugh-Curtis syndrome | X | ||
13.1.2.1.2 Tuboovarian abscess | X | ||
13.1.2.2 Urethritis | X | ||
13.1.2.3 Gangrene of perineum | X | X | |
13.1.3 Lesions | |||
13.1.3.1 Herpes simplex (See 4.4.4.3, 10.6.4) | X | ||
13.1.3.2 Human papillomavirus (HPV) (See 4.4.4.4) | X | ||
13.1.4 Ovary | |||
13.1.4.1 Cyst | X | ||
13.1.4.2 Torsion | X | ||
13.1.4.3 Tumors | X | X | |
13.1.5 Uterus | |||
13.1.5.1 Abnormal bleeding | X | X | |
13.1.5.2 Endometriosis | X | ||
13.1.5.3 Prolapse | X | ||
13.1.5.4 Tumors | X | X | |
13.1.5.4.1 Gestational trophoblastic disease | X | ||
13.1.5.4.2 Leiomyoma | X | ||
13.1.6 Vagina and vulva | |||
13.1.6.1 Bartholin's cyst | X | X | |
13.1.6.2 Foreign body | X | X | |
13.1.6.3 Vaginitis/Vulvovaginitis | X | ||
13.2 Normal Pregnancy | X | ||
13.3 Complications of Pregnancy | |||
13.3.1 Abortion | X | ||
13.3.2 Ectopic pregnancy | X | X | |
13.3.3 Hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome | X | X | |
13.3.4 Hemorrhage, antepartum | |||
13.3.4.1 Abruptio placentae (See 18.2.1) | X | X | |
13.3.4.2 Placenta previa | X | X | |
13.3.5 Hyperemesis gravidarum | X | X | |
13.3.6 Gestational hypertension | X | X | |
13.3.6.1 Eclampsia | X | X | |
13.3.6.2 Preeclampsia | X | ||
13.3.7 Infections | X | ||
13.3.8 Rh isoimmunization | X | ||
13.3.9 First trimester bleeding | X | X | X |
13.3.10 Gestational diabetes | X | X | |
13.4 High-risk Pregnancy | X | X | |
13.4.1 Assisted reproductive therapies | X | X | X |
13.4.2 Pre-existing medical problems | X | X | X |
13.5 Normal Labor and Delivery | X | X | |
13.6 Complications of Labor | |||
13.6.1 Fetal distress | X | ||
13.6.2 Premature labor (See 18.2.3) | X | ||
13.6.3 Premature rupture of membranes | X | ||
13.6.4 Rupture of uterus (See 18.2.4) | X | ||
13.7 Complications of Delivery | |||
13.7.1 Malposition of fetus | X | X | |
13.7.2 Nuchal cord | X | ||
13.7.3 Prolapse of cord | X | ||
13.7.4 Amniotic fluid embolism | X | X | |
13.8 Postpartum Complications | |||
13.8.1 Endometritis | X | ||
13.8.2 Hemorrhage | X | X | |
13.8.3 Mastitis | X | X | |
13.8.4 Pituitary infarction | X | X | |
13.9 Contraception | X | X | |
14.0 PSYCHOBEHAVIORAL DISORDERS | |||
Critical | Emergent | Lower Acuity | |
14.1 Substance Use Disorders | |||
14.1.1 Alcohol use disorder (See 17.1.1) | X | X | X |
14.1.2 Illicit drug use | X | X | X |
14.1.3 Prescription drug use | X | X | X |
14.1.3.1 Drug diversion | X | ||
14.1.4 Tobacco use disorder | X | ||
14.1.5 Withdrawal syndromes | X | X | X |
14.1.6 Opioid use disorder (17.1.2.3) | X | X | X |
14.1.7 Stimulant use disorder | X | X | X |
14.1.8 Medication-assisted treatment (MAT) | X | X | |
14.2 Mood Disorders and Thought Disorders | |||
14.2.1 Acute psychosis | X | X | |
14.2.2 Bipolar disorder | X | X | |
14.2.3 Depression | X | X | |
14.2.3.1 Suicidal risk | X | X | |
14.2.4 Grief reaction | X | ||
14.2.5 Schizophrenia | X | X | |
14.3 Factitious Disorders | X | X | |
14.4 Neurotic Disorders | |||
14.4.1 Anxiety/Panic | X | ||
14.4.2 Obsessive compulsive | X | ||
14.4.3 Phobic | X | ||
14.4.4 Post-traumatic stress | X | ||
14.5 Organic Psychoses | |||
14.5.1 Chronic organic psychotic conditions | X | ||
14.5.1.1 Alcoholic psychoses | X | X | |
14.5.1.2 Drug psychoses | X | X | |
14.5.2 Dementia (See 12.8.1) | X | ||
14.6 Patterns of Violence/Abuse/Neglect | |||
14.6.1 Interpersonal violence | |||
14.6.1.1 Child | X | X | X |
14.6.1.2 Intimate partner | X | X | X |
14.6.1.3 Elder | X | X | X |
14.6.2 Homicidal Risk | X | X | |
14.6.3 Sexual assault | X | ||
14.6.4 Staff/Patient safety | X | ||
14.6.5 Human trafficking | X | X | |
14.7 Personality Disorders | X | ||
14.8 Psychosomatic Disorders | |||
14.8.1 Hypochondriasis | X | ||
14.8.2 Hysteria/Conversion | X | ||
14.9 Feeding and Eating Disorders | X | X | X |
15.0 RENAL AND UROGENITAL DISORDERS | |||
Critical | Emergent | Lower Acuity | |
15.1 Acute and Chronic Renal Failure | X | X | X |
15.2 Complications of Dialysis | X | X | |
15.2.1 Vascular | X | X | X |
15.2.2 Peritoneal | X | X | X |
15.3 Glomerular Disorders | |||
15.3.1 Glomerulonephritis (See 9.4.4) | X | X | |
15.3.2 Nephrotic syndrome | X | X | |
15.4 Infection | |||
15.4.1 Cystitis | X | ||
15.4.2 Pyelonephritis | X | ||
15.4.3 Asymptomatic bacteriuria | X | ||
15.5 Male Genital Tract | |||
15.5.1 Genital lesions | X | ||
15.5.2 Hernias | X | X | |
15.5.3 Inflammation/Infection | |||
15.5.3.1 Balanitis/Balanoposthitis | X | X | |
15.5.3.2 Epididymitis/Orchitis | X | X | |
15.5.3.3 Gangrene of the perineum (Fournier's gangrene) | X | X | |
15.5.3.4 Prostatitis | X | X | |
15.5.3.5 Urethritis | X | ||
15.5.4 Structural | |||
15.5.4.1 Paraphimosis/Phimosis | X | ||
15.5.4.2 Priapism | X | ||
15.5.4.2.1 Medication induced | X | X | |
15.5.4.3 Prostatic hypertrophy (BPH) | X | ||
15.5.4.4 Torsion | X | ||
15.5.5 Testicular masses | X | ||
15.6 Nephritis | X | X | |
15.6.1 Hemolytic uremic syndrome | X | ||
15.7 Structural Disorders | |||
15.7.1 Calculus of urinary tract | X | X | |
15.7.2 Obstructive uropathy | X | X | |
15.7.3 Polycystic kidney disease | X | ||
15.8 Tumors | X | ||
16.0 THORACIC-RESPIRATORY DISORDERS | |||
Critical | Emergent | Lower Acuity | |
16.1 Acute Upper Airway Disorders | |||
16.1.1 Infections | |||
16.1.1.1 Croup | X | ||
16.1.1.2 Epiglottitis (See 7.4.5.1) | X | X | |
16.1.2 Obstruction/Foreign body (See 16.4.7) | X | ||
16.2 Disorders of Pleura, Mediastinum, and Chest Wall | |||
16.2.1 Costochondritis | X | ||
16.2.2 Mediastinitis | X | X | |
16.2.3 Pleural effusion | X | X | |
16.2.4 Pleuritis | X | ||
16.2.5 Pneumomediastinum | X | ||
16.2.6 Pneumothorax (See 18.1.2.7) | |||
16.2.6.1 Simple | X | ||
16.2.6.2 Tension | X | ||
16.2.6.3 Open | X | ||
16.2.7 Empyema | X | X | |
16.3 Acute Respiratory Distress Syndrome | X | X | |
16.4 Obstructive/Restrictive Lung Disease | |||
16.4.1 Asthma/Reactive airway disease | X | X | |
16.4.2 Bronchitis and bronchiolitis | X | X | |
16.4.3 Bronchopulmonary dysplasia | X | X | |
16.4.4 Chronic obstructive pulmonary disease | X | X | X |
16.4.5 Cystic fibrosis | X | X | X |
16.4.6 Environmental/Industrial exposure | X | X | X |
16.4.7 Foreign body (See 16.1.2) | X | X | |
16.5 Physical and Chemical Irritants/Insults | |||
16.5.1 Pneumoconiosis | X | X | |
16.5.2 Toxic effects of gases, fumes, vapors (See 18.1.3.3.2) | X | X | X |
16.6 Pulmonary Embolism/Infarct | |||
16.6.1 Septic emboli | X | X | |
16.6.2 Venous thromboembolism (See 3.3.2.1) | X | X | X |
16.6.2.1 Massive and submassive embolism | X | X | |
16.6.3 Fat emboli | X | X | |
16.7 Pulmonary Infections | |||
16.7.1 Lung abscess | X | ||
16.7.2 Pneumonia | |||
16.7.2.1 Aspiration | X | X | |
16.7.2.2 Community-acquired | X | X | X |
16.7.2.3 Hospital-acquired pneumonia | X | X | X |
16.7.2.4 Pneumocystis | X | X | X |
16.7.3 Pulmonary tuberculosis | X | ||
16.7.4 Respiratory syncytial virus (RSV) | X | X | X |
16.7.5 Pertussis | X | X | X |
16.8 Tumors | |||
16.8.1 Breast | X | ||
16.8.2 Pulmonary | X | X | |
16.9 Pulmonary Hypertension | X | X | X |
17.0 TOXICOLOGIC DISORDERS | |||
Critical | Emergent | Lower Acuity | |
17.1 Drug and Chemical Classes | |||
17.1.1 Alcohol (See 14.1.1) | |||
17.1.1.1 Ethanol | X | X | X |
17.1.1.2 Ethylene glycol | X | X | |
17.1.1.3 Isopropyl | X | X | X |
17.1.1.4 Methanol | X | X | |
17.1.2 Analgesics | |||
17.1.2.1 Acetaminophen | X | X | |
17.1.2.2 Nonsteroidal anti-inflammatories (NSAIDS) | X | X | |
17.1.2.3 Opioids (See 14.1.6) | X | X | |
17.1.2.4 Salicylates | X | X | |
17.1.3 Anticholinergics | X | X | |
17.1.3.1 Antihistamines | X | ||
17.1.4 Anticoagulants/Antithrombotics/Antiplatelets | X | X | |
17.1.4.1 Direct thrombin inhibitors | X | ||
17.1.4.2 Factor Xa inhibitors | X | ||
17.1.4.3 Heparins | X | X | |
17.1.4.4 Vitamin K antagonists | X | X | |
17.1.5 Anticonvulsants | X | X | |
17.1.6 Antidepressants | X | X | |
17.1.6.1 Bupropion | X | ||
17.1.6.2 Selective serotonin reuptake inhibitors | X | X | |
17.1.6.3 Tricyclic antidepressants | X | X | |
17.1.7 Antiemetics | X | ||
17.1.8 Antimicrobials | |||
17.1.8.1 Antibiotics | X | X | |
17.1.8.1.1 Isoniazid | X | X | |
17.1.8.2 Antimalarials | X | X | X |
17.1.8.3 Antiretrovirals | X | X | X |
17.1.9 Antipsychotics | X | X | |
17.1.10 Carbon monoxide | X | X | |
17.1.11 Cardiovascular drugs | |||
17.1.11.1 Antidysrhythmics | X | X | |
17.1.11.1.1 Digoxin | X | X | |
17.1.11.2 Antihypertensives | X | X | |
17.1.11.2.1 Central acting | X | X | |
17.1.11.2.2 Peripheral Acting | X | X | |
17.1.11.3 Beta blockers | X | X | |
17.1.11.4 Calcium channel blockers | X | X | |
17.1.12 Cholinergics | X | X | |
17.1.12.1 Nerve agents | X | X | |
17.1.12.2 Organophosphates | X | X | |
17.1.13 Cyanides, hydrogen sulfide | X | X | |
17.1.14 Heavy metals | X | X | |
17.1.15 Herbicides, insecticides, and rodenticides | X | X | |
17.1.16 Household/Industrial chemicals | X | X | X |
17.1.16.1 Caustic agents (See 2.2.2.3) | X | X | |
17.1.16.2 Hydrocarbons | X | X | |
17.1.16.3 Inhaled irritants | X | X | |
17.1.17 Hypoglycemics/Insulin | X | X | |
17.1.18 Lithium | X | X | X |
17.1.19 Local anesthetics | X | X | |
17.1.20 Marine toxins (See 6.1.3) | X | X | X |
17.1.21 Methemoglobinemia (See 8.5.3) | X | X | |
17.1.22 Mushrooms/Poisonous plants | X | X | |
17.1.23 Nutritional supplements | X | X | |
17.1.23.1 Iron | X | X | |
17.1.23.2 Performance enhancing and weight-loss drugs | X | X | X |
17.1.24 Recreational drugs | X | X | X |
17.1.24.1 Cannabis | X | ||
17.1.24.1.1 Cannabinoid hyperemesis syndrome/Cyclic vomiting (See 2.7.7) | X | ||
17.1.24.2 Synthetic cannabinoids | X | X | X |
17.1.24.3 Hallucinogens | X | X | X |
17.1.24.4 GHB | X | X | X |
17.1.25 Sedatives/Hypnotics | X | X | |
17.1.26 Stimulants/Sympathomimetics | X | X | |
17.1.26.1 Amphetamines | X | X | |
17.1.26.2 Cocaine | X | X | X |
18.0 TRAUMATIC DISORDERS | |||
Critical | Emergent | Lower Acuity | |
18.1 Trauma | |||
18.1.1 Abdominal trauma | |||
18.1.1.1 Diaphragm | X | X | |
18.1.1.2 Hollow viscus | X | X | |
18.1.1.3 Penetrating | X | X | |
18.1.1.4 Retroperitoneum | X | X | |
18.1.1.5 Solid organ | X | X | |
18.1.1.6 Vascular | X | X | |
18.1.1.7 Abdominal wall | X | X | |
18.1.2 Thoracic trauma | |||
18.1.2.1 Aortic dissection/Disruption | X | ||
18.1.2.2 Contusion | |||
18.1.2.2.1 Cardiac | X | X | X |
18.1.2.2.2 Pulmonary | X | X | |
18.1.2.3 Fracture | |||
18.1.2.3.1 Clavicle | X | X | |
18.1.2.3.2 Ribs/Flail chest | X | X | X |
18.1.2.3.3 Sternum | X | X | |
18.1.2.3.4 Scapula | X | X | |
18.1.2.4 Hemothorax | X | X | |
18.1.2.5 Penetrating chest trauma | X | X | |
18.1.2.6 Pericardial tamponade (See 3.6.1) | X | ||
18.1.2.7 Pneumothorax (See 16.2.6) | |||
18.1.2.7.1 Simple | X | ||
18.1.2.7.2 Tension | X | ||
18.1.2.7.3 Open | X | ||
18.1.3 Cutaneous trauma | |||
18.1.3.1 Avulsions | X | X | |
18.1.3.2 Bite wounds (See 6.1) | X | X | |
18.1.3.3 Burns | |||
18.1.3.3.1 Electrical (See 6.3) | X | X | X |
18.1.3.3.2 Chemical (See 16.5.2) | X | X | X |
18.1.3.3.3 Thermal | X | X | X |
18.1.3.4 Lacerations | X | X | |
18.1.3.5 Puncture wounds | X | X | |
18.1.3.6 Nail injuries | X | ||
18.1.4 Facial trauma | X | ||
18.1.4.1 Dental | X | X | |
18.1.4.2 Le Fort | X | X | X |
18.1.4.3 Mandibular | X | X | |
18.1.4.4 Orbital | X | X | |
18.1.4.5 Nasal | X | ||
18.1.4.5.1 Septal hematoma | X | ||
18.1.4.6 Zygomaticomaxillary complex | X | ||
18.1.5 Genitourinary trauma | |||
18.1.5.1 Bladder | X | ||
18.1.5.2 External genitalia | X | ||
18.1.5.3 Renal | X | X | |
18.1.5.4 Ureteral | X | ||
18.1.5.5 Urethral | X | X | |
18.1.6 Head trauma | |||
18.1.6.1 Intracranial injury | X | X | |
18.1.6.1.1 Concussion | X | X | |
18.1.6.1.2 Intracranial hemorrhage | X | X | |
18.1.6.2 Scalp lacerations/Avulsions | X | X | |
18.1.6.3 Skull fractures | X | X | |
18.1.7 Spine trauma | |||
18.1.7.1 Dislocations/Subluxations | X | X | |
18.1.7.2 Fractures | X | X | X |
18.1.7.3 Sprains/Strains | X | ||
18.1.8 Extremity bony trauma | |||
18.1.8.1 Dislocations/Subluxations | X | ||
18.1.8.2 Fractures (open and closed) | X | X | |
18.1.9 Neck trauma | |||
18.1.9.1 Laryngotracheal injuries | X | X | |
18.1.9.2 Penetrating neck trauma | X | X | |
18.1.9.3 Vascular injuries | X | X | |
18.1.9.4 Strangulation | X | X | X |
18.1.10 Ophthalmologic trauma | |||
18.1.10.1 Corneal abrasions/Lacerations (See 7.2.1.3) | X | X | |
18.1.10.2 Corneal burns (See 7.2.1.1) | |||
18.1.10.2.1 Acid | X | ||
18.1.10.2.2 Alkali | X | ||
18.1.10.2.3 Ultraviolet | X | X | |
18.1.10.3 Periorbital lacerations | X | ||
18.1.10.3.1 Eyelid | X | ||
18.1.10.3.2 Lacrimal duct | X | ||
18.1.10.4 Foreign body (See 19.4.4.8) | X | ||
18.1.10.5 Hyphema (See 7.2.2.2) | X | ||
18.1.10.6 Penetrating globe injuries | X | ||
18.1.10.7 Retinal detachments (See 7.2.3.4) | X | ||
18.1.10.8 Traumatic iritis (See 7.2.2.3) | X | X | |
18.1.10.9 Retrobulbar hematoma | X | ||
18.1.11 Otologic trauma | |||
18.1.11.1 Hematoma | X | X | |
18.1.11.2 Perforated tympanic membrane (See 7.1.7) | X | ||
18.1.12 Pediatric fractures | |||
18.1.12.1 Epiphyseal | X | X | |
18.1.12.1.1 Salter-Harris classification | X | X | |
18.1.12.2 Greenstick | X | ||
18.1.12.3 Torus | X | ||
18.1.12.4 Apophyseal avulsion | X | ||
18.1.13 Pelvic fracture | X | X | |
18.1.14 Soft-tissue extremity injuries | |||
18.1.14.1 Amputations/Replantation | X | ||
18.1.14.2 Compartment syndromes | X | ||
18.1.14.3 High-pressure injection | X | ||
18.1.14.4 Injuries to joints | X | X | |
18.1.14.5 Penetrating trauma | X | X | |
18.1.14.6 Periarticular | X | ||
18.1.14.7 Sprains/Strains | X | ||
18.1.14.8 Tendon injuries | |||
18.1.14.8.1 Lacerations/Transections | X | ||
18.1.14.8.2 Ruptures | X | X | |
18.1.14.9 Vascular injuries | X | X | |
18.1.15 Spinal cord and nervous system trauma | |||
18.1.15.1 Cauda equina syndrome (See 11.2.7.1) | X | X | |
18.1.15.2 Injury to nerve roots | X | X | |
18.1.15.3 Peripheral nerve injury | X | X | |
18.1.15.4 Spinal cord injury | X | X | X |
18.1.15.4.1 Spinal cord injury without radiologic abnormality (SCIWORA) | X | ||
18.2 Trauma in Pregnancy | |||
18.2.1 Abruptio placentae (See 13.3.4.1) | X | X | |
18.2.2 Resuscitative hysterotomy (See 19.4.8.2) | X | ||
18.2.3 Premature labor (See 13.6.2) | X | ||
18.2.4 Rupture of uterus (See 13.6.4) | X | ||
18.3 Multi-system Trauma | X | X | |
18.3.1 Blast injury | X | X | |
18.3.2 Falls | X | X | X |
18.3.3 Motor vehicle collision | X | X | X |
18.3.4 Assault | X | X | X |
19.0 PROCEDURES AND SKILLS INTEGRAL TO THE PRACTICE OF EMERGENCY MEDICINE | |||
19.1 Airway Techniques | |||
19.1.1 Intubation | |||
19.1.2 Airway adjuncts | |||
19.1.3 Surgical airway | |||
19.1.4 Mechanical ventilation | |||
19.1.5 Noninvasive ventilatory management | |||
19.1.6 Ventilatory monitoring | |||
19.2 Resuscitation | |||
19.2.1 Cardiopulmonary resuscitation | |||
19.2.2 Neonatal resuscitation | |||
19.2.3 Pediatric resuscitation | |||
19.2.4 Post-resuscitative care | |||
19.2.4.1 Therapeutic hypothermia (or targeted temperature management) | |||
19.2.5 Blood, fluid, and component therapy | |||
19.2.6 Arterial catheter insertion | |||
19.2.7 Central venous access | |||
19.2.8 Intraosseous line placement | |||
19.2.9 Defibrillation | |||
19.2.10 Thoracotomy | |||
19.2.11 Extracorporeal membrane oxygenation (ECMO) | |||
19.2.12 Thermoregulation procedures | |||
19.3 Anesthesia and Acute Pain Management | |||
19.3.1 Regional anesthesia | |||
19.3.2 Procedural sedation | |||
19.3.3 Analgesia | |||
19.4 Diagnostic and Therapeutic Procedures | |||
19.4.1 Abdominal and gastrointestinal | |||
19.4.1.1 Anoscopy | |||
19.4.1.2 Excision of thrombosed hemorrhoid | |||
19.4.1.3 Gastrostomy tube replacement | |||
19.4.1.4 Nasogastric tube | |||
19.4.1.5 Paracentesis | |||
19.4.1.6 Mechanical control of upper gastrointestinal bleeding | |||
19.4.2 Cardiovascular and Thoracic | |||
19.4.2.1 Cardiac pacing | |||
19.4.2.2 Cardioversion | |||
19.4.2.3 ECG interpretation | |||
19.4.2.4 Pericardiocentesis | |||
19.4.2.5 Thoracentesis | |||
19.4.2.6 Thoracostomy | |||
19.4.3 Cutaneous | |||
19.4.3.1 Escharotomy | |||
19.4.3.2 Incision and drainage | |||
19.4.3.3 Trephination, nails | |||
19.4.3.4 Wound closure techniques | |||
19.4.3.5 Wound management | |||
19.4.4 Head, ear, eye, nose, and throat | |||
19.4.4.1 Control of epistaxis | |||
19.4.4.2 Drainage of peritonsillar abscess | |||
19.4.4.3 Laryngoscopy | |||
19.4.4.4 Lateral canthotomy | |||
19.4.4.5 Slit lamp examination | |||
19.4.4.6 Tonometry | |||
19.4.4.7 Tooth stabilization | |||
19.4.4.8 Corneal foreign body removal (See 18.1.10.4) | |||
19.4.4.9 Drainage of hematoma | |||
19.4.5 Systemic infectious | |||
19.4.5.1 Personal protection (equipment and techniques) | |||
19.4.5.2 Universal precautions and exposure management | |||
19.4.6 Musculoskeletal | |||
19.4.6.1 Arthrocentesis | |||
19.4.6.2 Compartment pressure measurement | |||
19.4.6.3 Fracture/Dislocation immobilization techniques | |||
19.4.6.4 Fracture/Dislocation reduction techniques | |||
19.4.6.5 Spine immobilization techniques | |||
19.4.6.6 Fasciotomy | |||
19.4.7 Nervous system | |||
19.4.7.1 Lumbar puncture | |||
19.4.8 Obstetrics and gynecology | |||
19.4.8.1 Delivery of newborn | |||
19.4.8.2 Resuscitative hysterotomy (See 18.2.2) | |||
19.4.8.3 Sexual assault examination | |||
19.4.9 Psychobehavioral | |||
19.4.9.1 Psychiatric screening examination | |||
19.4.9.2 Violent patient management/Restraint | |||
19.4.10 Renal and urogenital | |||
19.4.10.1 Bladder catheterization | |||
19.4.10.1.1 Urethral catheter | |||
19.4.10.1.2 Suprapubic catheter | |||
19.4.10.2 Cystourethrogram | |||
19.4.10.3 Testicular detorsion | |||
19.4.11 Toxicologic | |||
19.4.11.1 Decontamination | |||
19.4.11.2 Antidote administration | |||
19.5 Ultrasound | |||
19.5.1 Diagnostic ultrasound | |||
19.5.2 Procedural ultrasound | |||
19.6 Other Diagnostic and Therapeutic Procedures | |||
19.6.1 Foreign body removal | |||
19.6.2 Collection and handling of forensic material | |||
20.0 OTHER CORE COMPETENCIES OF THE PRACTICE OF EMERGENCY MEDICINE | |||
20.1 Interpersonal and Communication Skills | |||
20.1.1 Interpersonal skills | |||
20.1.1.1 Inter-departmental and medical staff relations | |||
20.1.1.2 Intra-departmental relations, teamwork, and collaboration skills | |||
20.1.1.3 Patient and family experience of care | |||
20.1.2 Communication skills | |||
20.1.2.1 Complaint management and service recovery | |||
20.1.2.2 Conflict management | |||
20.1.2.3 Crisis resource management | |||
20.1.2.4 Delivering bad news/Death notifications | |||
20.1.2.5 Cultural competency | |||
20.1.2.6 Negotiation skills | |||
20.1.2.7 Management of patient expectations | |||
20.2 Practice-based Learning and Improvement | |||
20.2.1 Performance improvement and lifelong learning | |||
20.2.1.1 Evidence-based medicine | |||
20.2.1.2 Interpretation of medical literature | |||
20.2.1.3 Knowledge translation | |||
20.2.1.4 Patient safety and medical errors | |||
20.2.1.5 Performance evaluation and feedback | |||
20.2.1.6 Research | |||
20.2.2 Practice guidelines | |||
20.2.3 Education | |||
20.2.3.1 Patient and family | |||
20.2.3.2 Provider | |||
20.2.4 Principles of quality improvement | |||
20.3 Professionalism | |||
20.3.1 Advocacy | |||
20.3.1.1 Patient | |||
20.3.1.2 Professional | |||
20.3.1.3 Healthcare disparities | |||
20.3.2 Ethical principles | |||
20.3.2.1 Conflicts of interest | |||
20.3.2.2 Diversity and inclusion awareness | |||
20.3.2.3 Electronic communications/Social media | |||
20.3.2.4 Medical ethics | |||
20.3.2.5 Stewardship of resources | |||
20.3.2.6 Care of vulnerable populations | |||
20.3.3 Leadership and management principles | |||
20.3.4 Well-being and resilience | |||
20.3.4.1 Fatigue and impairment | |||
20.3.4.1.1 Sleep hygiene | |||
20.3.4.2 Time management/Organizational skills | |||
20.3.4.3 Work/Life balance | |||
20.3.4.4 Work dysphoria (burn-out) | |||
20.3.4.5 Job and contract evaluation | |||
20.3.4.6 Care for the caregiver | |||
20.4 Systems-based Practice | |||
20.4.1 Clinical informatics | |||
20.4.1.1 Computerized order entry | |||
20.4.1.2 Clinical decision support | |||
20.4.1.3 Electronic health record | |||
20.4.1.4 Health information exchange and interoperability | |||
20.4.2 ED Administration | |||
20.4.2.1 Contracts and practice models | |||
20.4.2.2 Patient flow and throughput | |||
20.4.2.2.1 Patient triage and classification | |||
20.4.2.2.2 Hospital crowding and diversion | |||
20.4.2.2.3 Observation and rapid treatment units | |||
20.4.2.3 Financial principles | |||
20.4.2.3.1 Billing and coding | |||
20.4.2.3.2 Cost-effective care and resource utilization | |||
20.4.2.3.3 Reimbursement issues | |||
20.4.2.4 Human resource management | |||
20.4.2.4.1 Allied health professionals | |||
20.4.2.4.2 Recruitment, credentialing, and orientation | |||
20.4.2.4.3 Staffing/Scheduling | |||
20.4.2.5 Emergency preparedness | |||
20.4.3 ED operations | |||
20.4.3.1 Policies and procedures | |||
20.4.3.2 ED data acquisition and operational metrics | |||
20.4.3.3 Safety, security, and violence in the ED | |||
20.4.3.4 Patient satisfaction | |||
20.4.4 Health care coordination | |||
20.4.4.1 Advance directives | |||
20.4.4.2 Palliative care | |||
20.4.4.2.1 Patient identification for palliative care | |||
20.4.4.2.2 Withdrawal of support | |||
20.4.4.2.3 Hospice referral | |||
20.4.4.3 Placement options | |||
20.4.4.3.1 Activities of daily living/Functional assessment | |||
20.4.4.4 Outpatient services | |||
20.4.4.5 Organ donation | |||
20.4.5 Regulatory/Legal | |||
20.4.5.1 Accreditation | |||
20.4.5.2 Compliance and reporting requirements | |||
20.4.5.3 Confidentiality and privacy | |||
20.4.5.4 Consent, capacity, and refusal of care | |||
20.4.5.5 Emergency Medical Treatment and Active Labor Act (EMTALA) | |||
20.4.5.6 External quality metrics | |||
20.4.5.7 Good Samaritan emergency care | |||
20.4.6 Risk management | |||
20.4.6.1 Liability and litigation | |||
20.4.6.2 Professional liability insurance | |||
20.4.6.3 Risk mitigation | |||
20.4.6.4 Error disclosure | |||
20.4.6.5 Root cause analysis | |||
20.4.7 Evolving trends in health care delivery | |||
20.4.7.1 Public policy | |||
20.4.7.2 Gender identity and sexual orientation | |||
20.4.7.2.1 Transgender care | |||
20.4.7.3 Social determinants of health | |||
20.4.7.4 Firearm injury prevention | |||
20.4.8 Regionalization of emergency care |
ED = emergency department.
The Accreditation Council for Graduate Medical Education (ACGME) requires each specialty to develop outcomes-based milestones for resident performance within the six general (core) competencies (i.e., patient care, medical knowledge, practice-based learning and improvement, interpersonal skills, professionalism, and system-based practice). The six general competencies are an integral part of the practice of emergency medicine and are embedded in the EM Model (
15
,16
). The EM Model is closely aligned with the general competencies, using section headings with similar terminology.The EM Model is designed for use as the core document for the specialty. It provides the foundation for developing medical school and residency curricula; certification examination specifications; continuing education objectives; research agendas; residency program review requirements; and other documents necessary for the definition, skills acquisition, assessment, and practice of the specialty. In conjunction with the EM Model, these six general competencies construct a framework for evaluation of physician performance and curriculum design to further refine and improve the education and training of competent emergency physicians. The six competencies and the EM Model also form the core of ABEM's continuing certification process. For further information on this process see ABEM's website (www.abem.org/).
Changes in the EM Model
The 2019 EM Model Review Task Force met to consider changes based on input received from the seven collaborating organizations. Each organization was asked to comment on how it uses the EM Model, identify changes in practice or updated evidence, and recommend changes in the document that would address any deficiencies. The changes recommended by the 2019 EM Model Review Task Force and accepted by the seven organizations can be found in the Appendix.
Current Uses of the EM Model
AAEM
AAEM uses the EM Model as a reference document to identify topics for annual conference programming.
ABEM
ABEM uses the EM Model to define its examination specifications. Each question or structured case used in any ABEM examination is referenced to the EM Model. Every test and examination that ABEM develops is based on a blueprint derived directly from the EM Model.
ACEP
ACEP uses the EM Model primarily as the basis for its educational activities. In addition, the ACEP Academic Affairs Committee uses the EM Model to align programming with academic educational needs. This information is used to develop a comprehensive list of web-based educational resources that can be incorporated into residency curricula.
CORD and the RRC-EM
The integration of the competencies into the EM Model meets the program requirements of the RRC-EM that the six core competencies are included in residency training. The EM Model is a major tool for CORD and Emergency Medicine program faculty to use when integrating the competencies into the training, residency curricula, and evaluation of residents.
EMRA
EMRA uses the EM Model as a reference document to identify content at risk for testing on the in-training and certification examinations.
SAEM
SAEM uses the EM Model as a reference document to identify topics and plan programming.
In summary, the EM Model is accomplishing the intended purposes for which it was developed. The 2019 review of the EM Model resulted in significant changes and clarifications, including the addition of an oncology section within Category 8, Hematologic and Oncologic Disorders. Several emergency medicine organizations are using the EM Model to support the ongoing development of the specialty of emergency medicine. The complete updated 2019 EM Model can be found on the websites of each of the eight collaborating organizations.
Acknowledgments
The 2019 Model of the Clinical Practice of Emergency Medicine is used with permission of the American Academy of Emergency Medicine, the American Board of Emergency Medicine, the American College of Emergency Physicians, the Council of Emergency Medicine Residency Directors, the Emergency Medicine Residents' Association, the Residency Review Committee for Emergency Medicine, and the Society for Academic Emergency Medicine, copyright 2020.
Supplementary Data
References
- Creating the model of a clinical practice: the case of emergency medicine.Acad Emerg Med. 2003; 10: 161-168
- Core Content Task Force II. The Model of the Clinical Practice of Emergency Medicine.Ann Emerg Med. 2001; 37: 745-770
- Core Content Task Force II. The Model of the Clinical Practice of Emergency Medicine.Acad Emerg Med. 2001; 8: 660-681
- The Model of the Clinical Practice of Emergency Medicine: a 2-year update.Ann Emerg Med. 2005; 45: 659-674
- The Model of the Clinical Practice of Emergency Medicine: a 2-year update.Acad Emerg Med. 2005; 12: 543-558
- The 2003 Model of the Clinical Practice of Emergency Medicine: the 2005 update.Ann Emerg Med. 2006; 48: e1-e17
- The 2003 Model of the Clinical Practice of Emergency Medicine: the 2005 update.Acad Emerg Med. 2006; 13: 1070-1073
- The 2005 Model of the Clinical Practice of Emergency Medicine: the 2007 update.Acad Emerg Med. 2008; 15: 776-779
- The 2005 Model of the Clinical Practice of Emergency Medicine: the 2007 update.Ann Emerg Med. 2008; 52: e1-e17
- The 2007 Model of the Clinical Practice of Emergency Medicine: the 2009 update.Acad Emerg Med. 2011; 18: e8-e26
- The 2007 Model of the Clinical Practice of Emergency Medicine: the 2009 update.Ann Emerg Med. 2011; 57: e1-e15
- The 2011 Model of the Clinical Practice of Emergency Medicine.Acad Emerg Med. 2012; 19: e19-e40
- The 2013 Model of the Clinical Practice of Emergency Medicine.Acad Emerg Med. 2014; 21: 574-598
- The 2016 Model of the Clinical Practice of Emergency Medicine.J Emerg Med. 2017; 52: 846-849
- Integrating the Accreditation Council for Graduate Medical Education Core Competencies into the Model of the Clinical Practice of Emergency Medicine.Ann Emerg Med. 2004; 43: 756-759
- Integrating the Accreditation Council for Graduate Medical Education Core Competencies into the Model of the Clinical Practice of Emergency Medicine.Acad Emerg Med. 2004; 11: 674-685
Article info
Publication history
Published online: May 28, 2020
Accepted:
March 18,
2020
Received:
February 6,
2020
Footnotes
Disclosure: Joshua S. Broder is a shareholder in OmniSono Inc. His spouse is employed by GlaxoSmithKline. The remaining authors disclose no conflicts.
Identification
Copyright
© 2020 American Board of Emergency Medicine. Published by Elsevier Inc.
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse
Elsevier's open access license policy

Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy